Filtros de búsqueda

Lista de obras de

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

artículo científico publicado en 2009

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

article

Body weight changes with beta-blocker use: results from GEMINI.

artículo científico publicado en 2007

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

artículo científico publicado en 2017

Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

scientific article published on 29 July 2019

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

artículo científico publicado en 2004

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

artículo científico publicado en 2019

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

article

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

article

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

scientific article published on 19 December 2018

Update on Biosimilar Insulins: A US Perspective

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda